Loading data
RRNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | 5.05 m USD | 4.24 m USD | 8.76 m USD | 6.05 m USD |
| Cost of revenue | 3.24 m USD | 1.54 m USD | 2.74 m USD | 2.1 m USD |
| Gross profit | 1.81 m USD | 2.7 m USD | 6.02 m USD | 3.95 m USD |
| Research and development expense | 3.3 m USD | 2.64 m USD | 1.98 m USD | 1.77 m USD |
| Operating profit | -17.2 m USD | -7.78 m USD | 289 k USD | -376 k USD |
| Profit before tax | -49.28 m USD | -942 k USD | -445 k USD | -394 k USD |
| Income tax expense | -96 k USD | 426 k USD | -106 k USD | 113 k USD |
| Net income (reported basis) | -49.07 m USD | -1.37 m USD | -339 k USD | -507 k USD |
| Net income attributable to common shareholders | -49.07 m USD | -1.37 m USD | -339 k USD | -507 k USD |
| Basic earnings per share | -0.4 USD/share | -0.02 USD/share | -0.01 USD/share | -0.01 USD/share |
| Diluted earnings per share | -0.4 USD/share | -0.02 USD/share | -0.01 USD/share | -0.01 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.